RIO DE JANEIRO, BRAZIL – Publicly traded Brazilian medical services firm Diagnósticos da América SA, known as DASA, said on Monday, March 15th, that in a securities filing that the board of the company has approved a proposed acquisition of two rival medical companies.
According to the filing, the board authorized its wholly owned subsidiary Ímpar Serviços Hospitalares SA to buy up to 100% of the stock of Andrade da Silva Participações SA and up to 100% of the stock capital of Mendes da Silva Participações SA.
DASA said the subsidiary has agreed to pay about R$400 million (US$72.05 million) in cash as part of the deal. The transaction will also entail issuance of some 12.5 million shares by Impar, which will be given as payment to the sellers, the filing said.
More: Brazil news in English, every day from The Rio Times.
This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error
Brazil runoff, Sunday, October 25: Brazil runoff: date, poll closing times and when results start. Latest: Brazil runoff polls, Flávio 51%, Lula 49%.